Discover the only laser on the market for the treatment of chronic low back pain. Our new FDA market cleared laser has been proven in double-blind, placebo-controlled, randomized, parallel group, multi-center clinical trial to effectively treat this painful condition. The participants of the FX 635 Clinical Trial showed a 58% pain reduction at 2 month follow-up evaluation. This trial went on to demonstrate that the FX 635 is successful in the treatment of chronic low back pain. The recent clearance of the FX 635 is groundbreaking for the pain management community and the war on opioids.
For patients and physicians looking for an opioid-free alternative to lower back pain treatment, low back pain laser therapy is proving to be to be a medical breakthrough with incredible results, no harmful side-effects and, most promising of all, no potential for addiction.